Oncology

Latest News

The investigators found that patients with SCLC and cachexia were more likely to have problems with treatment. | Image credit: appledesign - stock.adobe.com
Cachexia Worsens Prognosis in Older Patients With Advanced SCLC

July 9th 2025

Older patients with small cell lung cancer and significant weight loss were more likely to experience dose interruptions than patients with cachexia.

Insurance gaps | Image Credit: iQoncept-stock.adobe.com
Insurance Gaps Threaten Cancer Treatment Success

July 7th 2025

Analyzed by birth cohort, the authors found each successive birth cohort had a 7.7% decline in SCLC rates. | Image credit: shidlovski
Decline in SCLC Incidence Expected to Accelerate Through 2050

June 29th 2025

While elevated NLR previously served as a marker of aggressive disease and poor prognosis in SCLC, its prognostic relevance appears to diminish in the context of immunotherapy-based treatment regimens. | Image credit: Crystal light - stock.adobe.com
Challenging the Prognostic Role of NLR in SCLC in the Era of Immunotherapy

June 27th 2025

Gender rights | Image Credit: © Nadzeya-stock.adobe.com
Culture Key to Data Collection of Sexual Orientation and Gender Identity in Cancer Care

June 23rd 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations
Continuing Medical Education
View All
July 10th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
July 10th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

Oncology Value Coalition: Disparities in Cancer Care—Sources and Solutions, Part 3
April 22nd 2021

Oncology Value Coalition: Disparities in Cancer Care—Sources and Solutions, Part 3

In the inaugural Oncology Value Coalition from The American Journal of Managed Care®, Kashyap Patel, MD, led a discussion with Debra Patt, MD, PhD, MBA; and Karen Winkfield, MD, PhD, exploring findings that suggest minority groups develop cancer at higher rates and experience worse outcomes than nonminority groups.
Oncology Value Coalition: Disparities in Cancer Care—Sources and Solutions, Part 2
April 22nd 2021

Oncology Value Coalition: Disparities in Cancer Care—Sources and Solutions, Part 2

In the inaugural Oncology Value Coalition from The American Journal of Managed Care®, Kashyap Patel, MD, led a discussion with Debra Patt, MD, PhD, MBA; and Karen Winkfield, MD, PhD, exploring findings that suggest minority groups develop cancer at higher rates and experience worse outcomes than nonminority groups.
Oncology Value Coalition: Disparities in Cancer Care—Sources and Solutions, Part 1
April 22nd 2021

Oncology Value Coalition: Disparities in Cancer Care—Sources and Solutions, Part 1

In the inaugural Oncology Value Coalition from The American Journal of Managed Care®, Kashyap Patel, MD, led a discussion with Debra Patt, MD, PhD, MBA; and Karen Winkfield, MD, PhD, exploring findings that suggest minority groups develop cancer at higher rates and experience worse outcomes than nonminority groups.
Site Logo
April 12th 2021

Treatment Patterns for Patients With Advanced/Metastatic Cancers by Site of Care

Suvapun Bunniran, PhD Yihua Xu, PhD Cliff Molife, PhD Radhika Nair, PhD Yajun Emily Zhu, MS Gebra Cuyun Carter, PhD Sheetal Sheth, PharmD, BCOP Lisa M. Hess, PhD
Treatment patterns and overall survival were similar regardless of site of care between patients receiving anticancer therapy in the hospital outpatient vs physician office setting.
Dr Russell Langan
April 11th 2021

Dr Russell Langan Details Workflow for Cloud-Based Technology to Manage Pancreatic Cancer

Russell Langan, MD, chief of Surgical Oncology and Hepatopancreatobiliary Surgery at Saint Barnabas Medical Center discusses the workflow of a cloud-based data management platform for patients with pancreatic cysts.
A new AI device is aimed at helping GIs find areas of the colon that need further evaluation for possible cancer.
April 10th 2021

FDA Clears First AI Device to Find Possible Cancerous Hot Spots During Colonoscopies

AJMC Staff
The device, which highlights for gastroenterologists regions of the colon that have visual characteristics consistent with possible cancerous abnormalities, is already in use in Europe.
Image of skin tumor
April 7th 2021

Cancer Landscape to Shift by 2040, New Report Says

Allison Inserro
Cases of pancreatic and liver cancers are expected to rise by 2040, and there will be more melanoma cases, according to new estimates of future US cancer incidence and death.
Dr Russell Langan
April 2nd 2021

Dr Russell Langan on the Implementation of Cloud-Based Patient Surveillance

Russell Langan, MD, chief of Surgical Oncology and Hepatopancreatobiliary Surgery at Saint Barnabas Medical Center, details the implementation of the center's Pancreatic Cyst Surveillance Program.
busy hospital
March 26th 2021

Physician-Rating Websites vs Internal Patient Satisfaction Scores at a Large Cancer Center

Rose McNulty
The study was originally undertaken to convince MD Anderson’s providers that publishing survey results online would help their reputations.
NCCN
March 21st 2021

Better Record “Integration” Would Boost Links Between Oncologists, Primary Care

Mary Caffrey
A panel at the NCCN Virtual Annual Meeting finds that while primary care physicians and oncologists can share information, records may not be well integrated and in easy-to-use formats.
NCCN Virtual Annual Conference 2021
March 20th 2021

NCCN Panel Discusses Challenges, Potential Solutions for Racial Disparities in Cancer Care

Rose McNulty
A keynote session at the NCCN Virtual Annual Conference brought a panel of patient advocates and experts together for a timely and necessary discussion about strategies to reduce racial disparities in oncology.
NCCN Annual Virtual Conference
March 19th 2021

Benefits and Challenges of ePRO Implementation in Oncology

Rose McNulty
During a session at the National Comprehensive Cancer Network (NCCN) annual virtual conference, the payer perspective and physician experiences with PRO systems in both the community and academic medical center settings took center stage.
NCCN
March 18th 2021

White, Brown Bagging of Therapies Creates Extra Steps for Oncology Practices

Mary Caffrey
Pharmacists from the Cleveland Clinic discuss the impact of payer dispensing requirements, known as white bagging and brown bagging, on oncology practices and on patients.
Cancer Survivors Returning to Work: Barriers and Interventions
March 18th 2021

Cancer Survivors Returning to Work: Barriers and Interventions

Rose McNulty
Amye J. Tevaarwerk, MD, director of the Survivorship Program at the University of Wisconsin Carbone Cancer Center, discussed the impact that cancer diagnosis and treatment can have on survivors when it comes to work.
This Week in Managed Care: March 12, 2021
March 12th 2021

This Week in Managed Care: March 12, 2021

This week, the top news in managed care included CDC guidance on safe activities for fully vaccinated individuals; American Rescue Plan signed into law; new lung cancer screening criteria expand eligibility.
Lung Cancer
March 10th 2021

New USPSTF Lung Cancer Screening Criteria Cover More High-Risk Patients

Rose McNulty
Updated lung cancer screening recommendations from the U.S. Preventive Services Task Force include 2 changes that will nearly double the number of people eligible for screening.
Cancer Care From the COVID-19 Front Lines: “Flying by the Seat of Our Pants”
March 7th 2021

Cancer Care From the COVID-19 Front Lines: “Flying by the Seat of Our Pants”

Mary Caffrey
A panel at the Association of Community Cancer Centers discusses lessons from the year of COVID-19.
Electronic Patient Monitoring Demonstration
March 3rd 2021

Integrating Remote Symptom Management With ePROs in Cancer Care

Rose McNulty
A presentation at the ACCC 47th Annual Meeting & Cancer Center Business Summit gave virtual attendees an overview of research on PROs and how RSM can be incorporated into an oncology practice.
breast cancer
March 2nd 2021

Athenex Receives CRL on Oral Paclitaxel Plus Encequidar for Treatment of Metastatic Breast Cancer

Mary Caffrey
FDA's action marks an abrupt change of course from the Priority Review granted September 2020.
Kavita Patel
March 1st 2021

Kavita Patel: Drug Pricing, Care Access Priorities in Federal Health Care Policy

Rose McNulty
Kavita Patel, MD, MS, FACP, a fellow at the Brookings Institution Center for Health Policy, touched on key topics in health care at the ACCC 47th Annual Meeting and Cancer Center Business Summit.
Researcher in Laboratory
February 24th 2021

Oncolytic Virus, CAR T Combination Preclinical Study Shows Activity in Solid Tumors

Rose McNulty
Loading chimeric antigen receptor (CAR) T-cells with the oncolytic virus pelareorep improved their efficacy in solid tumor mouse models in a preclinical study presented at the CAR-TCR Summit Europe 2021.
Older Woman Speaking With Doctor
February 24th 2021

Real-World Outcomes Contrast Cancer Clinical Trial Results in Medicare Patients

Rose McNulty
Pivotal cancer clinical trial data may lack generalizability in older adults with Medicare, a study published online today in JAMA Network Open found.
FDA Approves Libtayo Monotherapy for First-Line Advanced NSCLC With PD-L1 Expression
February 22nd 2021

FDA Approves Cemiplimab for First-Line Advanced NSCLC With PD-L1 Expression

Rose McNulty
The PD-1 inhibitor cemiplimab-rwlc, sold as Libtayo, was FDA approved as a monotherapy for patients with first-line advanced non–small cell lung cancer (NSCLC) with PD-L1 expression of at least 50%.
Donald M. Berwick, MD, MPP
February 18th 2021

Use of COTA Nodal Address Highlights Variance in Cancer Care Cost: An Interview With Donald M. Berwick, MD, MPP

Mary Caffrey
Donald M. Berwick, MD, MPP, the former CMS administrator who is president emeritus and senior fellow at the Institute for Healthcare Improvement, discusses cost variation in cancer care found through the digital classification system the COTA Nodal Address.
Anne Hubbard, MBA
February 18th 2021

Radiation Oncology’s Role in the Next Chapter of Payment Reform

Anne Hubbard, MBA
An ideal alternative payment model would reward radiation oncologists for participation in a value-based payment arrangement that grants them the freedom to make care delivery decisions based on patient needs and in accordance with clinical guidelines, says ASTRO's Anne Hubbard, MBA.
Cosela Approved for Protection Against Myelosuppression From SCLC Treatment
February 17th 2021

Cosela Approved for Protection Against Myelosuppression From SCLC Treatment

Maggie L. Shaw
The cyclin-dependent kinase 4/6 inhibitor trilaciclib (Cosela) is the first in its class to receive FDA approval as a protective agent against bone marrow loss from treatment for small cell lung cancer (SCLC).
Amy Ellis, Northwest Medical Specialties
February 17th 2021

Amy Ellis: There Was a Big Shift to Telemedicine in Cancer Care Delivery

With the onset of the pandemic, the increased use of telemedicine has been the biggest change to how cancer care is being delivered; however, whether telemedicine is here to stay depends on the regulators and payers, said Amy Ellis, chief quality officer at Northwest Medical Specialties.
Flying the Plane While You Build It
February 16th 2021

Flying the Plane While You Build It

Joseph Alvarnas, MD
In this issue of Evidence-Based Oncology™ we see a foreshadowing of what the future of cancer care innovation could look like and how we may learn to move forward, safely, at an ever-accelerating pace.
DNA Analysis
February 10th 2021

Liquid Biopsy Demonstrates Clinical Utility in Advanced Prostate Cancer

Rose McNulty
A new study assessed the genomic alterations identified by ctDNA analysis compared with tissue-based comprehensive genomic profiling in patients with metastatic castration-resistant prostate cancer.
Amy Ellis, Northwest Medical Specialties
February 3rd 2021

Amy Ellis on the Benefits of ePROs in Cancer Care

Electronic patient-reported outcomes (ePROs) tools can benefit patients by keeping them on treatment longer, and the pandemic has likely accelerated how many practices move to using ePROs, said Amy Ellis, chief quality officer at Northwest Medical Specialties.
<1
...
161718192021222324
...
186>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo